Get the Stockscreener App
39.49
3.16%
-1.29
Inari Medical Inc stock is currently priced at $39.49, with a 24-hour trading volume of 1.23M.
It has seen a -3.16% decreased in the last 24 hours and a -2.85% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $40.95 pivot point. If it approaches the $39.28 support level, significant changes may occur.
Inari Medical Inc Stock (NARI) Financials Data
Inari Medical Inc (NARI) Revenue 2023
NARI reported a revenue (TTM) of $493.63 million for the quarter ending December 31, 2023, a +28.73% rise year-over-year.
Inari Medical Inc (NARI) Net Income 2023
NARI net income (TTM) was -$1.64 million for the quarter ending December 31, 2023, a +94.41% increase year-over-year.
Inari Medical Inc (NARI) Cash Flow 2023
NARI recorded a free cash flow (TTM) of $29.73 million for the quarter ending December 31, 2023, a +224.26% increase year-over-year.
Inari Medical Inc (NARI) Earnings per Share 2023
NARI earnings per share (TTM) was -$0.03 for the quarter ending December 31, 2023, a +94.55% growth year-over-year.
Inari Medical Inc Stock (NARI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hoffman William | Director |
Mar 18 '24 |
Sale |
41.13 |
40,000 |
1,645,079 |
1,003,296 |
| Hill, Mitch C. | Chief Financial Officer |
Mar 12 '24 |
Option Exercise |
0.46 |
6,000 |
2,742 |
189,361 |
| Hill, Mitch C. | Chief Financial Officer |
Mar 12 '24 |
Sale |
41.91 |
6,000 |
251,461 |
183,361 |
| Hoffman William | Director |
Dec 15 '23 |
Sale |
65.08 |
25,000 |
1,627,073 |
1,045,493 |
| Hill, Mitch C. | Chief Financial Officer |
Dec 12 '23 |
Option Exercise |
0.46 |
6,500 |
2,970 |
176,730 |
| Hill, Mitch C. | Chief Financial Officer |
Dec 12 '23 |
Sale |
62.75 |
6,500 |
407,855 |
170,230 |
| Hoffman William | Director |
Dec 04 '23 |
Option Exercise |
0.43 |
103,492 |
44,336 |
1,070,493 |
| Hykes Andrew | President and CEO |
Nov 16 '23 |
Sale |
59.82 |
37,448 |
2,240,277 |
434,817 |
| Tu Thomas | Chief Medical Officer |
Nov 16 '23 |
Sale |
59.82 |
25,451 |
1,522,573 |
320,932 |
| Hoffman William | Director |
Nov 15 '23 |
Sale |
61.24 |
25,000 |
1,531,124 |
967,001 |
Inari Medical Inc Stock (NARI) Latest News
What 8 Analyst Ratings Have To Say About Inari Medical
Benzinga
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
GlobeNewswire Inc.
Why You Should Retain Inari Medical (NARI) Stock for Now
Zacks Investment Research
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
GlobeNewswire Inc.
Market Cap Game Show: Andy Cross vs. Bill Mann
The Motley Fool
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
About Inari Medical Inc
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.
COMPANY PROFILE
NameInari Medical Inc
SectorHealthcare (1198)
IndustryMedical Devices (161)
Web
Phone877-923-4747
Employee240
Twitter
@InariMedical
SEC filings
Latest SEC Filings
Next earning date2024-05-01
Address9 Parker, Suite 100, Irvine, CA, United States (92618)
1.74%
1.37%
Cap:
|
Volume (24h):